Skip to main content
Premium Trial:

Request an Annual Quote

ARUP, ASI Collaborate to Optimize Image Analysis for Digital Pathology

NEW YORK (GenomeWeb) – Applied Spectral Imaging said today that it is teaming up with ARUP Laboratories to develop and commercialize advanced digital pathology solutions with the aim of making pathology, cytogenetics, and research lab workflows more efficient.

As part of a multi-year strategic collaboration, the companies will develop image quality and analysis algorithms that resolve bottlenecks and make it easier for lab workers to manage and access clinical data, ASI said. The imaging platform could transform the way pathologists deliver professional services from remote locations, the firm added.

As a result of the collaboration, ASI will also be able to provide an imaging solution to its customer base that best supports fluorescent in situ hybridization and brightfield workflows, ASI CEO Limor Shiposh said in a statement.

Mohamed Salama, ARUP's chief of hematopathology, added that the national reference laboratory is seeing increasing volumes of pathology samples that require advanced workflow efficiencies, as well as creative data management and accessibility solutions. 

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.